<DOC>
	<DOCNO>NCT02855827</DOCNO>
	<brief_summary>Ovarian cryopreservation one available option preserve fertility prior potentially sterilize treatment . In absence technique vitro folliculogenesis injection isolate ovarian follicle , tissue re-used autograft . In France , first live birth orthotopic ovarian transplantation , obtain Roux et al . 2009 . This clinical trial aim build cohort patient likely use ovarian tissue cryopreserved autograft .</brief_summary>
	<brief_title>Constitution Cohort Monitoring Patients Candidating Ovarian Tissue Autograft</brief_title>
	<detailed_description>Ovarian cryopreservation one available option preserve fertility prior potentially sterilize treatment . In absence technique vitro folliculogenesis injection isolate ovarian follicle , tissue re-used autograft . In France , first live birth orthotopic ovarian transplantation , obtain Roux et al . 2009 . This clinical trial aim build cohort patient likely use ovarian tissue cryopreserved autograft . This cohort use : - Follow patient cryopreserved ovarian tissue ; - Evaluate request ovarian tissue grafting ; - Propose search residual disease case neoplastic disease risk ( possible ) ; - Allowing patient benefit ovarian tissue autograft ; - Assess effectiveness autograft technique restoration ovarian function .</detailed_description>
	<criteria>Patients cryopreserved ovarian tissue ; Patients premature ovarian insufficiency ; Patients older 11 year ( bone age ) induction puberty ; Patients age 18 43 year restoration ovarian function ; No objection patient Patients already receive ovarian tissue autograft . Patients age 11 year ( bone age ) ; Patients older 43 year ; Patients refuse include ; Patients ( adult ) guardianship , curator safeguard justice</criteria>
	<gender>Female</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>